Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Regeneron to Sequence 500K UK Biobank Genomes

A biotech company and health database center are partnering with drug maker GlaxoSmithKline to produce genomic data on 500,000 individuals for drug discovery. . . . → Read More: Regeneron to Sequence 500K UK Biobank Genomes

Inhaled Drug Shown Feasible for Postpartum Bleeding

Results from a clinical trial show a dry-powder inhaled form of the drug oxytocin works in the body much like the injected form, given to prevent postpartum hemorrhage, excessive bleeding in some women after childbirth. . . . → Read More: Inhaled Drug Shown Feasible for Postpartum Bleeding

Trial to Test Gene Therapy for Inherited Eye Disease

A spin-off enterprise from University of Oxford in the U.K. began enrolling participants in a clinical trial testing gene therapy to correct a genetic eye disease. . . . → Read More: Trial to Test Gene Therapy for Inherited Eye Disease

Organ Transplant Start-Up Gains $38M in Early Funds

A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round. . . . → Read More: Organ Transplant Start-Up Gains $38M in Early Funds

Simpler Method Devised to Produce Malaria Drug

A biochemistry group in the U.K. developed simpler and potentially more efficient techniques for producing a first-line drug for treating malaria. . . . → Read More: Simpler Method Devised to Produce Malaria Drug

Allergan to Option Gene Editing for Eye Diseases

International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard. . . . → Read More: Allergan to Option Gene Editing for Eye Diseases

Trial Shows Bioactive Glass Stops Bone Infections

Grafts of glass-based substitute material were shown in a clinical trial to stop bacterial bone infections from osteomyelitis, in most cases without additional antibiotics. . . . → Read More: Trial Shows Bioactive Glass Stops Bone Infections

Nanotech Gel Designed to Treat Snake Bites

A team from University of California in Irvine developed a snake bite treatment that in lab tests stops venom more effectively and at lower cost than current antidotes. . . . → Read More: Nanotech Gel Designed to Treat Snake Bites

Precision Medicine, “My Hope for the Future”

A meeting on Capitol Hill in Washington, D.C. today heard about one person’s struggle with cystic fibrosis and her hope for precision medicine to provide a cure. . . . → Read More: Precision Medicine, “My Hope for the Future”

Trial Underway to Test Cancer Immunotherapy Aid

A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system. . . . → Read More: Trial Underway to Test Cancer Immunotherapy Aid